- ►annals.org Y Imai, S Kawata, S Tamura, I Yabuuchi, S … - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: The effect of interferon therapy on the incidence of ... Cited by 184 - Related articles - BL Direct - All 4 versions
A Kasahara, N Hayashi, K Mochizuki, M … - Hepatology, 1998 - interscience.wiley.com To elucidate the risk factors for liver carcinogenesis and to examine the
incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022
chronic hepatitis C patients treated with interferon were followed by ... Cited by 274 - Related articles - BL Direct - All 3 versions
K Ikeda, S Saitoh, Y Arase, K Chayama, Y … - Hepatology, 1999 - journals.pasteur.ac.ir The activity of interferon (IFN) is not elucidated from the viewpoint of cancer
prevention in chronic hepatitis C patients en masse. The hepatocellular
carcinogenesis rate was analyzed statistically in 1,643 patients with ... Cited by 241 - Related articles - BL Direct - All 5 versions
T Okanoue, Y Itoh, M Minami, S Sakamoto, K … - Journal of hepatology, 1999 - Elsevier Results: Sustained (SR: 27.5%) and transient (TR: 23.0%) responders totaled
50.5%, while 49.5% did not respond to interferon. SR showed an improvement in
disease stage reflected by increased platelet counts. Fifty-two patients (9 ... Cited by 116 - Related articles - BL Direct - All 5 versions
G Mazzella, E Accogli, S Sottili, D Festi, M … - Journal of hepatology, 1996 - Elsevier Results: Over mean follow-up periods of 49 months for hepatitis B virus and 32
months for hepatitis C virus, patients ( hepatitis B virus and hepatitis C
virus) developed hepatocellular carcinoma. The risk of developing this ... Cited by 228 - Related articles - BL Direct - All 5 versions
DC Valla, M Chevallier, P Marcellin… - Gastroenterology, 1999 - medscape.com Journal Scan is the clinician's guide to the latest clinical research findings
in Gastroenterology, Hepatology, Gastrointestinal Endoscopy, and The New England
Journal of Medicine. Short summaries of feature articles include links to ... Cited by 127 - Related articles - BL Direct - All 4 versions
L Serfaty, H Aumaitre, O Chazouillères, AM … - Hepatology, 1998 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 287 - Related articles - BL Direct - All 3 versions
G Fattovich, G Giustina, F Degos, G Diodati, … - Journal of hepatology, 1997 - Elsevier Results: The yearly incidence of hepatocellular carcinoma was 2.3% for 136
untreated patients and 1.0% for 193 patients treated with interferon alfa. The
yearly incidence of hepatic decompensation was 5.7 for untreated and 1.4 ... Cited by 139 - Related articles - BL Direct - All 6 versions
S Nishiguchi, T Kuroki, S Nakatani, H … - The Lancet, 1995 - Elsevier In a prospective randomised controlled trial, we evaluated the effects of IFN-α
in cirrhotic patients with HCV infection because of their high risk of
hepatocellular carcinoma. 90 patients with compensated chronic active ... Cited by 651 - Related articles - BL Direct - All 7 versions
